课题基金 / 基金详情

项目摘要

项目成果

Angela McKoy的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):拟议研究的目标是应用结构、生物化学和生物物理分析,以发现HIV-逆转录酶核糖核酸酶H活性的新型抑制剂。HIV-1逆转录酶(RT)是逆转录病毒的中心酶和特征酶,是许多关键抗艾滋病药物的作用靶点。RT具有两种酶活性,DNA聚合酶和核糖核酸酶H(RNH)。尽管RT利用DNA聚合酶和RNH活性来进行合成,但迄今为止,所有已被批准用于临床使用的RT抑制剂都靶向聚合酶活性,而不是RNH活性。鉴于病毒的能力,突变,成为耐药,这是至关重要的,以探索RN抑制剂作为潜在的抗艾滋病治疗药物。虽然已经发现几种RNH抑制剂抑制RNH活性,但抑制剂结合机制的可视化可以推动基于结构的更有效的抗病毒药物的设计。该项目的目标是为了提供X射线晶体学领域的培训,并利用这些技能在发现和设计新的HIV-1 RT抑制剂。第一个目标将是使用X射线晶体学来确定活性位点和变构RNH抑制剂结合到HIV-1 RT的结构,并建立结构-活性关系和详细的结合模式。为了发现RNH抑制剂的新化学类别,将使用表面等离子体共振和X射线晶体学分析1500个药物样片段的文库与HIV-1 RT的潜在结合,并使用基于荧光的高通量筛选来分析RNH抑制,该筛选专门针对RNA切割。片段筛选方法允许有效的搜索化学空间,并应导致识别新的支架抑制HIV-1 RNH活性的活性位点和变构口袋。 公共卫生相关性:这项研究有助于发现、开发和理解新型抗艾滋病药物,特别是那些靶向核糖核酸酶H活性的药物。靶向核糖核酸酶H的药物的成功开发将显著扩大治疗HIV感染的选择。
英文摘要
DESCRIPTION (provided by applicant): The goal of the proposed research is to apply structural, biochemical, and biophysical analysis in an effort to discover novel inhibitors of HIV- reverse transcriptase ribonuclease H activity. HIV-1 reverse transcriptase (RT) is a central and characteristic enzyme of retroviruses, and is the target of many key anti-AIDS drugs. RT possesses two enzymatic activities, a DNA polymerase and a ribonuclease H (RNH). Although RT utilizes both DNA polymerase and RNH activities to carry out synthesis, to date, all RT inhibitors that have been approved for clinical use target the polymerase activity, not the RNH activity. Given the virus' ability to mutate and become drug resistant, it is crucial to explore RN inhibitors as potential anti-AIDS therapeutic agents. Though several RNH inhibitors have been found to inhibit RNH activity, visualization of inhibitor binding mechanisms could drive structure-based design of more effective antiviral drugs. The project goals are designed in order to provide training in the field of X-ray crystallography and utilize those skills in discovery and design of novel inhibitors of HIV-1 RT. The first goal will be to use X-ray crystallography to determine the structures of both active site and allosteric RNH inhibitors bound to HIV-1 RT and establish structure-activity relationships and detailed binding modes. In an effort toward the discovery of novel chemical classes of RNH inhibitors, a library of 1500 drug-like fragments will be analyzed for potential binding to HIV-1 RT using surface plasmon resonance and X-ray crystallography, and for RNH inhibition using a fluorescence based high throughput screen that looks specifically for RNA cleavage. The fragment screening approach allows for efficient search of chemical space and should lead to the identification of novel scaffolds for inhibiting HIV-1 RNH activity at both the active site and allosteric pockets. PUBLIC HEALTH RELEVANCE: The proposed research contributes to the discovery, development, and understanding of novel anti-AIDS drugs, particularly those that target the ribonuclease H activity. Successful development of a drug targeting ribonuclease H would significantly expand options for treating HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Novel HIV-1 Reverse Transcriptase Inhibitors by Fragment Screening
  • 批准号:
    8413487
  • 项目类别:
  • 资助金额:
    $4.92万
  • 财政年份:
    2012
  • 负责人:
    Angela McKoy
  • 依托单位:
海外基金